d.marchand
Submits third-party assay reports on material purchased directly. Based in Graz.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.50%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041934 | Semaglutide | TFC | TFC-2604-X4301 | PeptideMeter | 2026-Q3 | 98.91 | 3.76 | 92.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043584 | MOTS-c | BCH | BCH-2601-S7929 | Kestrel | 2026-Q1 | 98.50 | 6.49 | 88.7 | Supplier-supplied | 2 | FAIL |
| AX-2025-019342 | Liraglutide | TFC | TFC-2510-C7425 | VendorInvestigate | 2025-Q4 | 97.97 | 4.27 | 95.8 | Buyer-sourced | 1 | FAIL |
| AX-2025-020737 | Afamelanotide | SGN | SGN-2510-R8898 | Janoshik | 2025-Q4 | 98.29 | 4.71 | 103.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020511 | TB-500 | KP | KP-2510-V5596 | Medutest | 2025-Q4 | 98.42 | 4.45 | 100.6 | Laboratory-retained | 2 | FAIL |
| AX-2025-020129 | Retatrutide | GGPeps | GGPE-2508-E8992 | Janoshik | 2025-Q3 | 97.97 | 2.40 | 105.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020495 | CJC-1295 with DAC | KP | KP-2506-L5639 | Janoshik | 2025-Q3 | 99.80 | 5.00 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019701 | Tirzepatide | HJ | HJ-2501-P2892 | Kestrel | 2025-Q1 | 99.41 | 2.13 | — | Supplier-supplied | 3 | FAIL |
| AX-2025-018762 | TB-500 | QSC | QSC-2411-X7470 | Kestrel | 2025-Q1 | 99.34 | 5.80 | 98.3 | Supplier-supplied | 1 | MARGINAL |